Hypertension: Measure Well, Then Individualize

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

State the issuing organization, population, year, and recommendation strength. Do not equate every target or risk calculator with universal applicability.

What BP pattern and risk are being treated?. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

What BP pattern and risk are being treated?. Verified measurement — Standardized technique and out-of-office pattern; Risk and comorbidity — Kidney disease, cardiovascular risk and organ findings; Treatment tolerance — Symptoms, postural BP and patient priorities. State which guideline and measurement method define the target; do not mix frameworks silently. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Pressure reflects multiple mechanisms

Volume, vascular resistance, autonomic and hormonal activity, arterial stiffness, and medications contribute. Reliable measurement comes before classification.

Confirm the average before escalating

Use a validated upper-arm device, correct cuff, quiet seated rest, supported back/arm, and repeated readings. Add home or ambulatory measurement when white-coat or masked hypertension is plausible. A routine office value and a standardized research-style value are not automatically interchangeable.

Assess risk and secondary causes

Review cardiovascular and kidney disease, organ damage, sleep apnea, medications, endocrine clues, and treatment adherence.

Use the 2025 AHA/ACC treatment branch

Medication plus lifestyle treatment is recommended for average BP ≥140/90 mmHg, and for selected adults at ≥130/80 with CVD, prior stroke, diabetes, CKD, or PREVENT 10-year CVD risk ≥7.5%. Apply pregnancy, frailty, and other population-specific considerations rather than using a risk score mechanically.

Reassess effects and harms

Track home pressures, orthostatic symptoms, electrolytes, kidney function, and daily function after changes.

Interpret guidelines accurately

State the issuing organization, population, year, and recommendation strength. Do not equate every target or risk calculator with universal applicability.

Supporting evidence

Continue learning